Results 161 to 170 of about 1,222 (189)

Von In‐Silico bis In‐Cerebro – Entwicklung des Orexinrezeptor Antagonisten „Photorexant“ zur Photomodulation In Vitro und im Gehirn der Maus

Angewandte Chemie, EarlyView.
Durch einen strukturbasierten Designansatz wurden photoschaltbare Derivate des von der FDA zugelassenen Arzneistoffes Suvorexant entwickelt, gedockt, synthetisiert und pharmakologisch an den Orexin‐1‐ und 2‐Rezeptoren (OX1R und OX2R) charakterisiert.
Marcus Angermann, Marie H. Deventer, Vicente Ledesma‐Martin, Nuno Martinho, Alix Flake, Silvia Mori, Angel Nuñez, Jaime Pignatelli, Rita C. Guedes, Christophe P. Stove, Michael Decker   +10 more
wiley   +1 more source

[Lessons learned in the implementation of measles and rubella vaccination campaigns in the AmericasLições aprendidas com a implementação de campanhas de vacinação contra sarampo e rubéola na Região das Américas]. [PDF]

Rev Panam Salud Publica
Durón R, Pastor D, Whittembury Á, Rocha Queiroz Lemos D.   +3 more
europepmc   +1 more source

[Comprehensive approach to the interruption of the measles outbreak in Venezuela, 2017-2019: lessons learnedAbordagem integral para a interrupção do surto de sarampo na Venezuela, 2017-2019: lições aprendidas]. [PDF]

Rev Panam Salud Publica
Muro L, Castillo L, Rodríguez L, D'Angelo P, Porras N, García JM, Valderrama N, Rodriguez R, Villalobos N, Torres C, Villavicencio V.   +10 more
europepmc   +1 more source

The health economic-industrial complex: production and innovation for universal health access, Brazil. [PDF]

Bull World Health Organ
Gadelha CA, Maretto G, Nascimento MA, Kamia F.   +3 more
europepmc   +1 more source

Declaration of Santo Domingo: commitment to improve education, regulations, public policies, and access to peritoneal dialysis in Latin America. [PDF]

J Bras Nefrol
Moretta-Pedernera GL, Ramos-Sánchez A, Cortés-Sanabria L, Chaúd-Covarrubias R, Álvarez-Estévez G, Uribe M, Sánchez-Polo V, Divino-Filho JC, Wasmuth-Troche NM, Batista-Buitrago L, Avellán-Boza M, Orozco-Bass R, Martínez-Eusebio H, Soto-Velásquez R, Papaginovic-Leiva MM, Gómez-Luján M, Rodríguez-Manzano S, Rodríguez-Chagolla JM, Molina-Comboni DA, Álvarez-González Y, Crespo PJD, Campos EI, Moura-Neto JA, Hinojosa M, Vásquez-Jiménez LC, García-Villalobos GG, González G, Dina-Batle E, Álvarez-Novoa JR.   +28 more
europepmc   +1 more source

Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia. [PDF]

Hematol Transfus Cell Ther
Nascimento AD, Curado DDSP, Montezuma T, Barbosa WB, Machado-Rugolo J, Fachi MM.   +5 more
europepmc   +1 more source

Satisfaction and Workload as Predictors of Psychological Distress in Professionals of Psychosocial Care Centers During the COVID-19 Pandemic. [PDF]

Nurs Rep
Pinto DMS, Lourenção LG, Eid LP, Ponce MAZ, André JC, Tiol EBM, Giacon-Arruda BCC, Arruda GO, Souza MDGG, Sasaki NSGMDS, Santos ER, Martinez WD, Costa ACS, Engel AMRPVTC, da Silva Júnior AJ, Werneck AL, Souza MR, Martins MA, Silva GCS, Menezes JDS, Silva MQD, Pompeo DA.   +21 more
europepmc   +1 more source

La nueva Ley orgánica de Ministerios en Argentina

Documentación Administrativa, 2011
doaj   +1 more source

[Ranking of immunization programs in Latin America, 2020Ranking dos programas de vacinação na América Latina, 2020]. [PDF]

Rev Panam Salud Publica
Rombini MF, Mauas RP, Katz N, Urueña A.
europepmc   +1 more source